vanadates has been researched along with dasatinib in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Connelly, SF; Gomes, EG; Summy, JM | 1 |
| Acharya, C; Baty, CJ; Cline, R; Durgampudi, C; Husain, SZ; Karlsson, J; Mishra, V; Navina, S; Noel, P; Orlichenko, L; Patel, K; Singh, VP; Stolz, DB; Trivedi, RN | 1 |
2 other study(ies) available for vanadates and dasatinib
| Article | Year |
|---|---|
Targeting the yin and the yang: combined inhibition of the tyrosine kinase c-Src and the tyrosine phosphatase SHP-2 disrupts pancreatic cancer signaling and biology in vitro and tumor formation in vivo.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Cell Line, Tumor; Cell Movement; Cell Survival; Dasatinib; Drug Synergism; Extracellular Signal-Regulated MAP Kinases; Humans; Mice; Mice, Nude; Molecular Targeted Therapy; Pancreatic Neoplasms; Phosphorylation; Protein Kinase Inhibitors; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Proto-Oncogene Proteins c-akt; Pyrimidines; RNA Interference; Signal Transduction; src-Family Kinases; Thiazoles; Tumor Burden; Vanadates; Xenograft Model Antitumor Assays | 2013 |
Src Dependent Pancreatic Acinar Injury Can Be Initiated Independent of an Increase in Cytosolic Calcium.
Topics: Acinar Cells; Animals; Calcium; Cytosol; Dasatinib; Enzyme Activation; Fluorescent Antibody Technique; Mice; Mice, Inbred ICR; src-Family Kinases; Vanadates | 2013 |